NRC
IBB icon

New Republic Capital’s iShares Biotechnology ETF IBB Stock Holding History

New Republic Capital’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-25
Closed -$3.43K – 250
2024
Q2 		$3.43K Buy
+25
New +$3.34K ﹤0.01% 235
2023
Q3 		– Sell
-380
Closed -$48.2K – 230
2023
Q2 		$48.2K Hold
380
– – 0.03% 181
2023
Q1 		$49.1K Buy
+380
New +$49.7K 0.04% 170

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

New Republic Capital's IBB Position: Q3 2024 in Review

New Republic Capital sold out of iShares Biotechnology ETF (IBB) in Q3 2024, closing a stake of 25 shares — an estimated $3.43K sold.

New Republic Capital first reported a position in IBB in Q1 2023 and held it in 3 quarters. The position peaked at $49.1K in Q1 2023. 893 funds tracked by Wall St. Rank hold IBB as of Q3 2024.

  • New Republic Capital reported no remaining iShares Biotechnology ETF position as of Q3 2024 after selling out during the quarter.
  • New Republic Capital sold 25 iShares Biotechnology ETF shares in Q3 2024, an estimated $3.43K.
  • New Republic Capital first reported a position in iShares Biotechnology ETF in Q1 2023 and held it in 3 quarters.
  • New Republic Capital's iShares Biotechnology ETF position peaked at $49.1K in Q1 2023.
  • 893 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2024.

Based on New Republic Capital's 13F filing for Q3 2024, filed 4 Nov 2024.